BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24751554)

  • 21. Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide testing by MTBDRsl in Armenia.
    Margaryan H; Farnia P; Hayrapetyan A; Mirzoyan A
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S159-S160. PubMed ID: 28043525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.
    Kim DH; Kim HJ; Park SK; Kong SJ; Kim YS; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Lee CH; Shim TS
    Am J Respir Crit Care Med; 2010 Jul; 182(1):113-9. PubMed ID: 20224066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
    Habibnia S; Karami-Zarandi M; Zaker S; Ghalavand Z; Doustdar F; Eslami G; Kazemian H
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
    Zhang Z; Li T; Qu G; Pang Y; Zhao Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.
    Feuerriegel S; Cox HS; Zarkua N; Karimovich HA; Braker K; Rüsch-Gerdes S; Niemann S
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3353-6. PubMed ID: 19470506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates].
    Cui ZL; Wang XL; Wang J; Lu JM; Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):505-9. PubMed ID: 20979796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of indirect drug susceptibility testing using the MODS assay for the detection of XDR-TB in China.
    Huang ZK; Luo Q; Xiong GL; Li WT; Xu XM; Li JM
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):461-5. PubMed ID: 24670703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.
    Tang S; Zhang Q; Yu J; Liu Y; Sha W; Sun H; Fan L; Gu J; Hao X; Yao L; Xiao H
    Scand J Infect Dis; 2011 Apr; 43(4):280-5. PubMed ID: 21247226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and molecular characterization of amikacin resistance among Mycobacterium tuberculosis clinical isolates from southern China.
    Islam MM; Tan Y; Hameed HMA; Liu Y; Chhotaray C; Cai X; Liu Z; Lu Z; Wang S; Cai X; Su B; Li X; Tan S; Liu J; Zhang T
    J Glob Antimicrob Resist; 2020 Sep; 22():290-295. PubMed ID: 32142951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
    Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution and transmission patterns of extensively drug-resistant tuberculosis in China.
    Wang F; Shao L; Fan X; Shen Y; Diao N; Jin J; Sun F; Wu J; Chen J; Weng X; Cheng X; Zhang Y; Zhang W
    Antimicrob Agents Chemother; 2015 Feb; 59(2):818-25. PubMed ID: 25403663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.
    Jnawali HN; Yoo H; Ryoo S; Lee KJ; Kim BJ; Koh WJ; Kim CK; Kim HJ; Park YK
    World J Microbiol Biotechnol; 2013 Jun; 29(6):975-82. PubMed ID: 23329063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation and Transmission Profiles of Second-Line Drug Resistance in Clinical Isolates of Drug-Resistant
    Li Q; Gao H; Zhang Z; Tian Y; Liu T; Wang Y; Lu J; Liu Y; Dai E
    Front Microbiol; 2019; 10():1838. PubMed ID: 31447823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
    Wang D; Yang C; Kuang T; Lei H; Meng X; Tong A; He J; Jiang Y; Guo F; Dong M
    Jpn J Infect Dis; 2010 Sep; 63(5):368-71. PubMed ID: 20859008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
    Barnard M; Warren R; Gey Van Pittius N; van Helden P; Bosman M; Streicher E; Coetzee G; O'Brien R
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1298-305. PubMed ID: 23087027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.